Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-23-003896
Date:2023-02-01
Issuer: AKERO THERAPEUTICS, INC. (AKRO)
Original Submission Date:

Reporting Person:

CHENG ANDREW
C/O AKERO THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-02-01 M 25,000 a $0.62 395,999 direct
COMMON STOCK 2023-02-01 S 14,845 d $48.57 381,154 direct
COMMON STOCK 2023-02-01 S 8,155 d $49.67 372,999 direct
COMMON STOCK 2023-02-01 S 2,000 d $50.14 370,999 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.615 2023-02-01 deemed execution date M 25,000 (d) 2028-10-17 common stock 25,000 $0.62 160,868 direct
Footnotes
IDfootnote
f1 the reported transaction was effected pursuant to a rule 10b5-1 trading plan dated november 14, 2022, previously adopted by the reporting person.
f2 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $48.03 to $49.01, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this form 4.
f3 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $49.045 to $50.04, inclusive.
f4 the price reported in column 4 is a weighted-average price. these shares were sold in multiple transactions at prices ranging from $50.06 to $50.31, inclusive.
f5 the options are vested and currently exercisable.
WhaleWisdom Logo

Elevate your investments